Chromobacterium violaceum associated with recurrent vaginal discharge among apparently healthy females in Ekpoma, Nigeria

Ezera, Agwu and John Cletus, Ihongbe and Godwin Ray Anugboba, Okogun and Joseph Obiezu Chukwujekwu, Ezeonwumelu and Osamuyime, Igbinovia (2007) Chromobacterium violaceum associated with recurrent vaginal discharge among apparently healthy females in Ekpoma, Nigeria. [Journal (On-line/Unpaginated)]

Full text available as:



Seven hundred and two high vaginal swab samples of apparently healthy adult females with recurrent vaginal discharge were collected and analyzed at Searchlight Medical Diagnostic Centre, Ekpoma between July 2003 and August 2005. Isolation, identification and antibiogram of isolates were done using standard Microbiological techniques. Randomized Block Design and Completely Randomized Design at (α = 0.1) were used to test the statistical significance of results. While occupational distribution of isolates was not statistically significant, age and response of bacterial isolates to antibiotics used were statistically significant. Total number and percentage prevalence of bacteria isolated include: 297(42.4%) Chromobacterium violaceum, 156 (22.2%) Escherichia coli and 139 (19.8%) Staphylococcus aureus. Chromobacterium violaceum was 81.8% sensitive to ofloxacin, and 12.8% to Ceftriazone. Escherichia coli and S. aureus were 70.5% and 71.9% sensitive to sparfloxacin respectively. Though source of infection of C. violaceum in Ekpoma was not very clear, soil and water contamination and other risk factors were hypothesized. A high index of suspicion is required for diagnosis. Surveillance with improved diagnostic facilities can increase awareness among health care providers on this form of infection. Appropriate systemic antimicrobial therapy to halt progression of infection is mandatory, even when the infection appears to be localized.

Item Type:Journal (On-line/Unpaginated)
Keywords:Chromobacterium violaceum, Recurrent vaginal discharge, Ekpoma
Subjects:JOURNALS > Online Journal of Health and Allied Sciences
ID Code:5713
Deposited By: Kakkilaya Bevinje, Dr. Srinivas
Deposited On:18 Sep 2007 02:41
Last Modified:11 Mar 2011 08:56

References in Article

Select the SEEK icon to attempt to find the referenced article. If it does not appear to be in cogprints you will be forwarded to the paracite service. Poorly formated references will probably not work.

1. Healthlink worldwide. All About STDs and AIDS. Action Newsletter, 1994; Issue 16.

2. Wooley PG. Bacillus violaceum manilae (a pathogenic organism). Bull Johns Hopkins Hosp. 1905; 16: 89.

3. Sneath PHA, Whelan JPF, Singh RB, Edwards D. Fatal infection by Chromobacterium violaceum. Lancet. 1953; 2: 276–7.

4. Macher AM, Casale TB, Fauci AS. Chronic granulomatous disease of Childhood and Chromobacterium violaceum infections in the South-Eastern United States. Ann Intern Med.1982; 97: 51-5.

5. Bradley D, Bilton MD, Lester W, Johnson MD. Louisiana State University. Recurrent Nonfatal Chromobacterium violaceum Infection in a Nonimmunocompromised Patient. Infect Med. 2000; 17(10): 686-689.

6. Martin WJ, Martin SA. Carlimatobacterium, Cardiobacterium, Chromobacterium and streptobacillus, In Collier, L., Ballows, A., Sussman, M., Topley and Wilson’s Microbiology and Microbial Infections. Systematic Bacteriology, Volume 2, Arnold Publishers, London. 1998; 1217-1229

7. Nnaji J, Afoke A, Moses ALO. Association of Bacterial Vaginosis to Human Immunodeficiency Virus (HIV) Infection among Women in Abakaliki Metropolis. Journal of Biomedical Science in Africa. 2004; 2(1): 35-37.

8. Barrow GI, Feltham RKA. Cowan and Steel’s Manual for the Identification of Medical Bacteria. 1993, 3rd ed. Cambridge University Press, UK.

9. Cheesbrough M. District Laboratory Practice in Tropical Countries. 2004; Vol II, 2nd ed. Cambridge University Press, UK.

10. Raphael SS. Lynch’s Medical Laboratory Technology. 1983; 4th Ed. WB Saunders Company London.

11. National Committee for Clinical Laboratory Standards, Performance Standards for antimicrobial disc susceptibility tests. Wayne, Pennsylvania National Committee for Clinical Laboratory Standards. NCCLS document M2- A7, 2000.

12. National Committee for Clinical Laboratory Standards. Performance Standards for antimicrobial disk susceptibility tests: approved standard M2-A6. 1997; Wayne, PA: National Committee for Clinical Laboratory Standards.

13. National Committee for Clinical Laboratory Standards. Performance Standard for antimicrobial susceptibility testing: eleventh informational supplement. Wayne Pennsylvania National Committee for Clinical Laboratory Standards. NCCLS Documents M100 –S11, 2000.

14. Randomized block designs. NIST/SEMATECH e-Handbook of Statistical Methods. 2006. Available at

15. Onile A, Sobowale BO, Odugbemi T. Human infection due to Chromobacterium violaceum: a report from Ilorin, Nigeria. East Afr Med J. 1984; 61: 849-52.

16. Dromigny JA, Fall AL, Diouf S, Perrier-Gross-Claude JD. Chromobacterium violaceum: a case of diarrhea in Senegal. The Pediatric Infectious Disease Journal. 2002; 21(6): 573-574.

17. Agwu E, Ohihion AA, Agba MI, Okogun GRA, Okodua M, Tatfeng YM, Nwobu GO. Incidence of Streptococcus Pneumoniae Infections Among Patients Attending Tuberculosis Clinics in Ekpoma, Nigeria. Shiraz Electronic Medical Journal (SEMJ). 2006;7(1):1-8.

18. Alexander HG, Paolo R, Kim J. Analysis of HIV and CMV specific memory T-cell response during primary and chronic infections. Blood. 2002;100(4):1381-1387.

19. Angel JB, Parato KG, Kunner A. Progressive HIV specific immune recovery after prolonged viral suppression. Journal of infectious Disease. 2001;183(4):546-554.

20. Balint GA. Situation analysis of HIV/AIDS epidemic in sub-Saharan Africa. East African Medical Journal. 1998;75(12):684-696

21. Newton ER, Piper J, Pears W. Bacteria vaginosis and intra amniotic infections. Up date. AMF Physician. AMJ Obster Gynecol. 1997;176:672-675.

22. Sirinavin S, Techasaensiri C, Benjaponpitak S, Pornkul R, Vorachit M. Invasive Chromobacterium violaceum infection in children: case report and review. Pediatr Infect Dis J. 2005;24:559-61.

23. Agwu E, Agba MI, Nwobu GO, Isibor JO, Okpala HI, Ohihion AA, Uzoaru SC. Pattern of Bacterial Urinary Tract Infection Among Female Students of National Veterinary Research Institute Vom. Journal of Biomedical Science in Africa. 2004;2(2):15-17.

24. Teoh AYB, Hui M, Ngo KY, Wong J, Lee, KF, Lai PBS. Fatal septicaemia from Chromobacterium violaceum: case reports and review of the literature. Hong Kong Med J. 2006;12(3):228-231.

25. Public Health Agency of Canada. Guidelines on susceptibility testing of antibiotic-resistant Enterobacteriaceae due to extended spectrum beta-lactamases (ESBLs). 2002 updated.

26. Agwu E, Agba, MI, Nwobu, GO, Ongey JY, Inyang NJ, Imharebhor JA. Antimicrobial Resistance Profile of Streptococcus pneumoniae isolated from Suspected Tuberculosis Patients in Ekpoma and environs. Shiraz Electronic Medical Journal (SEMJ). 2004;5(3):1-11

27. Dutta S, Dutta SK. Multidrug resistant Chromobacterium violaceum: an unusual bacterium causing long standing wound abscess. Indian J Med Microbiol. 2003;21:217-8.

28. Nuoti JP, Butler JC, Crutcher JM, Guevara R, Welch D, Holder I. An outbreak of multidrug resistant pneumococcal pneumonia and bacteremia among unvaccinated nursing home resident. N Engl J Med. 1998;338:1861–8.


Repository Staff Only: item control page